Department of Biochemistry and Molecular Biology, Wright State University School of Medicine, Dayton, OH 45435, USA.
Mol Cell Biol. 2010 Sep;30(18):4492-506. doi: 10.1128/MCB.00229-10. Epub 2010 Jul 20.
We report the molecular mechanisms that underlie chemotaxis of macrophages and cell migration of fibroblasts, cells that are essential during the body's innate immune response and during wound repair, respectively. Silencing of phospholipase D1 (PLD1) and PLD2 reduced cell migration (both chemokinesis and chemotaxis) by approximately 60% and >80%, respectively; this migration was restored by cell transfection with PLD2 constructs refractory to small interfering RNA (siRNA). Cells overexpressing active phospholipase D1 (PLD1) but, mostly, active PLD2 exhibited cell migration capabilities that were elevated over those elicited by chemoattractants alone. The mechanism for this enhancement is complex. It involves two pathways: one that is dependent on the activity of the lipase (and signals through its product, phosphatidic acid [PA]) and another that involves protein-protein interactions. The first is evidenced by partial abrogation of chemotaxis with lipase activity-defective constructs (PLD2-K758R) and by n-butanol treatment of cells. The second is evidenced by PLD association with the growth factor receptor-bound protein 2 (Grb2) through residue Y(169), located within a Src homology 2 (SH2) consensus site. The association Grb2-PLD2 could be visualized by fluorescence microscopy in RAW/LR5 macrophages concentrated in actin-rich membrane ruffles, making possible that Grb2 serves as a docking or intermediary protein. The Grb2/PLD2-mediated chemotaxis process also depends on Grb2's ability to recognize other motility proteins, like the Wiskott-Aldrich syndrome protein (WASP). Cell transfection with WASP, PLD2, and Grb2 constructs yields the highest levels of cell migration response, particularly in a macrophage cell line (RAW/LR5) and only modestly in the fibroblast cell line COS-7. Further, RAW/LR5 macrophages utilize for cell migration an additional pathway that involves S6 kinase (S6K) through PLD2-Y(296), known to be phosphorylated by epidermal growth factor receptor (EGFR) kinase. Thus, both fibroblasts and macrophages use activity-dependent and activity-independent signaling mechanisms. However, highly mobile cells like macrophages use all signaling machinery available to them to accomplish their required function in rapid immune response, which sets them apart from fibroblasts, cells normally nonmobile that are only briefly involved in wound healing.
我们报告了巨噬细胞趋化和成纤维细胞迁移的分子机制,这些细胞分别在机体固有免疫反应和伤口修复过程中起着至关重要的作用。沉默磷脂酶 D1(PLD1)和 PLD2 可使细胞迁移(趋化运动和趋化运动)分别减少约 60%和 80%;通过细胞转染对 siRNA 具有抗性的 PLD2 构建体可恢复这种迁移。过表达活性磷脂酶 D1(PLD1)但主要是活性 PLD2 的细胞表现出的迁移能力高于趋化剂单独作用所引起的迁移能力。这种增强的机制很复杂。它涉及两条途径:一条途径依赖于脂酶的活性(并通过其产物磷脂酸(PA)发出信号),另一条途径涉及蛋白质-蛋白质相互作用。第一个途径的证据是用脂酶活性缺陷构建体(PLD2-K758R)部分阻断趋化作用和用正丁醇处理细胞。第二个途径的证据是 PLD 与生长因子受体结合蛋白 2(Grb2)通过位于Src 同源 2(SH2)基序内的残基 Y(169)结合。通过荧光显微镜可以观察到 RAW/LR5 巨噬细胞中富含肌动蛋白的膜皱襞中集中的 Grb2-PLD2 关联,这使得 Grb2 可能作为对接或中介蛋白。Grb2-PLD2 介导的趋化过程也依赖于 Grb2 识别其他运动蛋白(如 Wiskott-Aldrich 综合征蛋白(WASP))的能力。用 WASP、PLD2 和 Grb2 构建体转染细胞可产生最高水平的细胞迁移反应,特别是在巨噬细胞系(RAW/LR5)中,而在成纤维细胞系 COS-7 中则适度。此外,RAW/LR5 巨噬细胞利用涉及 S6 激酶(S6K)的另一条途径通过 PLD2-Y(296)进行细胞迁移,该途径已知通过表皮生长因子受体(EGFR)激酶磷酸化。因此,成纤维细胞和巨噬细胞都使用依赖活性和不依赖活性的信号机制。然而,像巨噬细胞这样的高迁移性细胞利用它们所有可用的信号机制来完成它们在快速免疫反应中的必需功能,这使它们与成纤维细胞区分开来,成纤维细胞通常是非移动细胞,仅在伤口愈合过程中短暂参与。